Interviews

Merging AI and Quantum Computing To Boost Drug Discovery

by Andrii Buvailo, PhD  (contributor )   •     

Disclaimer: All opinions expressed by Contributors are their own and do not represent those of their employers, or BiopharmaTrend.com.
Contributors are fully responsible for assuring they own any required copyright for any content they submit to BiopharmaTrend.com. This website and its owners shall not be liable for neither information and content submitted for publication by Contributors, nor its accuracy.

Share:   Share in LinkedIn  Share in Bluesky  Share in Reddit  Share in Hacker News  Share in X  Share in Facebook  Send by email

Quantum computing is a growing trend due to recent major advances in hardware making this technology a practically feasible thing. Some experts compare today’s rapid progress in quantum computing with a similar period during the last century when personal computing was emerging through a cascade of technological advances both in hardware and software. 

Will quantum change everything? When? Are we there yet? 

To find our insights about the above questions and learn a thing or two about what the quantum computing industry looks like today, I sat down with Dr. Christopher Savoie, Co-founder, and CEO at Zapata Computing -- an American quantum software company on the cutting-edge of research in this area. 

#advertisement
AI in Drug Discovery Report 2025

Continue reading

This content available exclusively for BPT Mebmers

Topics: AI & Digital   

Share:   Share in LinkedIn  Share in Bluesky  Share in Reddit  Share in Hacker News  Share in X  Share in Facebook  Send by email

You may also be interested to read: